/
/
Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Un abonnement à JoVE est nécessaire pour voir ce contenu. Connectez-vous ou commencez votre essai gratuit.
1Adelaide Medical School,University of Adelaide, 2South Australian Health and Medical Research Institute (SAHMRI), 3Department of Pathology,Nagoya University Graduate School of Medicine, 4Division of Molecular Pathology, Center for Neurological Disease and Cancer,Nagoya University Graduate School of Medicine, 5Department of Gastroenterology, Graduate School of Medicine,The University of Tokyo, 6Translational and Clinical Research Institute,Newcastle University, 7International Center for Cell and Gene Therapy,Fujita Health University
Chapitres
- 00:04Introduction
- 01:18Portal Vein Injection of Colorectal Cancer Organoids
- 05:39Results: Liver Metastases, Tumor Growth Kinetics, Bone Morphogenetic Protein Signaling and Tumor Proliferation Induced by Portal Vein AAV8-Injection
- 07:29Conclusion
Portal vein injection of colorectal cancer (CRC) organoids generates stroma-rich liver metastasis. This mouse model of CRC hepatic metastasis represents a useful tool to study tumor-stroma interactions and develop novel stroma-directed therapeutics such as adeno-associated virus-mediated gene therapies.
